FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction

News
Article

The combination of the Aurora SPECT/CT system with AI-enabled Clarify DL image reconstruction reportedly offers the potential of enhanced image quality and streamlined workflows in nuclear medicine.

The Food and Drug Administration (FDA) has granted 510(k) clearance for the Aurora single photon emission computed tomography/computed tomography (SPECT/CT) system and Clarify DL deep learning image reconstruction.

GE HealthCare, the developer of the dual-head Aurora SPECT/CT system, said the device offers the following key benefits:

FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction

The newly FDA-cleared dual-head Aurora SPECT/CT system has a 40 mm detector, which offers twice the coverage of CTs from other hybrid systems, and 128-slice capabilities across imaging applications in neurology, cardiology, and oncology, according to GE HealthCare, the developer of the Aurora SPECT/CT platform. (Image courtesy of GE HealthCare.)

• a 40 mm detector offering twice the coverage of CTs from other hybrid systems;

• 128-slice capabilities across imaging applications in neurology, cardiology, and oncology; and

• a 5/8-inch crystal Nal detector, which allows use of a variety of radiopharmaceuticals including theranostics.

Through advanced deep learning technology, GE HealthCare maintained that Clarity DL image reconstruction bolsters quality for bone SPECT imaging without the need for increased radiation dosing or scan time.

“Aurora’s seamless integration of SPECT and CT components will allow us to perform comprehensive, high-quality diagnostic exams in a single session, while its support of Clarify DL deep-learning image reconstruction enables enhanced image quality performance,” noted Donna Plecha, M.D., chair of the Department of Radiology at University Hospitals Cleveland Medical Center, and a professor of radiology at the Case Western Reserve University School of Medicine in Cleveland.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.